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Mastoiditis 
 
Background 
1. Definition  
o Inflammatory process of mastoid air cells in temporal bone 
2. General information  
o Complication of acute otitis media (AOM) 
o Occurrence rate higher in countries with restricted antibiotic use
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Pathophysiology 
1. Pathology of disease  
o Most commonly extension of AOM through aditus and antrum into mastoid 
air cells  
 Inflammation of mastoid epithelium blocks adequate drainage and 
creates opportunity for infection 
o Causes  
 Consider usual organisms as AOM, plus P.aeruginosa 
 Consider drug resistance in recently treated AOM 
 Estimated prevalence of most common pathogens
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 Pseudomonas aeruginosa (12-34%) 
 Streptococcus pneumoniae (14-32%) 
 Haemophilus influenzae (14%) 
 Group A streptococcus (3-26%) 
 Polymicrobial (6%) 
 Staphylococcal epidermidis (5%) 
 Enterococcus (5-9%) 
 Staphylococcal aureus (2-5%) 
 Moraxella catarrhalis 
 Potential complications (total estimated rate 15-55%)
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 Hearing loss, labyrinthitis, and vertigo 
 Potential to spread to CNS  
 Meningitis, brain abscess, epidural abscess 
 Septic thrombosis of lateral venous sinus 
 Behold abscess (below pinna or behind sternomastoid m.) 
 Chronic mastoiditis (most commonly associated with gram-
negative enteric bacteria) 
 Osteomyelitis  
 Sigmoid sinus thrombus 
 Gradenigo syndrome (otitis media, retro-orbital pain, 
abducens palsy)  
 Facial nerve (CN VII) palsy 
 Subperiosteal abscess and osteitis 
2. Incidence, prevalence  
o 1.2/10,000 child-years incidence in UK between 1990-2006
7
  
o Most common at age 6-13 mo 
o Equal incidence in males and females 
o May be severe in elderly 
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3. Risk factors  
o Inadequate treatment of acute otitis media 
o Cholesteatoma 
4. Morbidity/mortality  
o Hearing loss, vertigo, facial weakness or other cranial nerve involvement, 
labyrinthitis 
 
Diagnosis 
1. History  
o Fever, earache, pain over mastoid region 
2. Physical exam  
o Pain, swelling, erythema, and tenderness over mastoid prominence 
o Displacement of auricle anterior, lateral, and inferior 
o Fever 
o Virtually always otitis media (middle ear effusion with erythema of 
tympanic membrane or otalgia) or otorrhea, possible sagging of postero 
superior canal wall 
o May have hearing loss and otalgia 
3. Diagnostic testing  
o Diagnosis can be made clinically; imaging can be reserved for suspected 
complications
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o Mastoid plain radiograph (low sensitivity) hazy mastoid, opacification of 
normally air filled sinuses  
o CT of temporal bone opacification of mastoid air cells 
o Culture, gram stain of tympanocentesis fluid 
o Audiography to evaluate for hearing loss 
o Consider MRI for evaluation of surrounding soft tissues 
o There is no consensus on definitive diagnostic criteria 
 
Differential Diagnosis 
1. Otitis media  
2. Otitis externa 
3. Trauma to pinna or postauricular area 
4. Cellulitis 
5. Inflammation of posterior auricular nodes 
6. Tumors 
 
Therapeutics 
1. Admit for systemic abx  
o Cefotaxime 1 g IV q4hr OR  
o Ceftriaxone 2 g IV q24hr 
2. Further mgmt  
o Consider myringotomy or tympanostomy; mastoidectomy if no response to 
IV antibiotics, surgical drainage of abscess if intracranial extension, 
fluctuant mass behind ear, bony destruction 
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Follow-Up 
1. Two weeks of PO antibiotics after completed IV course 
2. Follow-up with ENT specialist with audiogram to assess for hearing loss 
 
Prognosis 
1. Early stages reversible with appropriate antibiotic treatment; later stages may 
require surgical drainage 
2. Full recovery if course uncomplicated 
 
Prevention 
1. Antibiotic treatment of AOM reduces the risk of mastoiditis by 50%, but the NNT 
is more than 2100
2
  
 
Patient Education 
1. MedlinePlus patient information on Mastoiditis 
(http://www.nlm.nih.gov/medlineplus/ency/article/001034.htm) 
2. University of Virginia Health System patient information on Mastoiditis 
(http://www.healthsystem.virginia.edu/uvahealth/peds_ent/mastoid.cfm) 
3. Merck Manual Home Edition entry on Mastoiditis 
(http://www.merck.com/mmhe/sec19/ch220/ch220h.html) 
 
References  
1. Van Zuijlen DA, Schilder AG, Van Balen FA, Hoes AW. National differences in 
incidence of acute mastoiditis: relationship to prescribing patterns of antibiotics for 
acute otitis media. Pediatr Infect Dis J 2001;20:140-44. 
2. Nussinovitch M, Yoeli R, Elishkevitz K, and Varsano I. Acute mastoiditis in 
children: epidemiologic, clinical, microbiologic, and therapeutic aspects over past 
years. Clin Pediatr (Phila) 2004;43;261. 
3. Butbul-Aviel Y, Miron D, Halevy R, et al. Acute mastoiditis in children: 
pseudomonas aeruginosa as a leading pathogen. Int J Pediatr Otorhinolaryngol. 
2003;67(3):277-281. 
4. Katz A, Leibovitz E, Greenberg D, et al. Acute mastoiditis in Southern Israel: a 
twelve year retrospective study (1990 through 2001). Pediatr Infect Dis J 
2003;22(10):878-82. 
5. Stähelin-Massik J, Podvinec M, Jakscha J, et al. Mastoiditis in children: a 
prospective, observational study comparing clinical presentation, microbiology, 
computed tomography, surgical findings, and histology. Eur J Pediatr 2008; 
167(5):541-8. 
6. Oestreicher-Kedem Y, Raveh E, Kornreich L, et al. Complications of mastoiditis in 
children at the onset of a new millennium. Ann Otol Rhinol Laryngol 
2005;114(2):147-52. 
7. Thompson PL, Gilbert RE, Long PF, et al. Effect of antibiotics for otitis media on 
mastoiditis in children: a retrospective cohort study using the United Kingdom 
general practice research database. Pediatrics 2009;123(2):424-30. 
 
 
 
Mastoiditis Page 4 of 4    9.17.09 
Author:  Brandon Dearman, Jonathan Adams, MD, & Franklin Berkey, DO,  
Penn State Hershey Medical Center 
 
Editor:  Vince WinklerPrins, MD, Georgetown University-Providence Hospital, 
Washington, DC 
